Cargando…

The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study

BACKGROUND: Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the present study was to evaluate the usefulness of CA125 in the detection of ovarian cancer recurrence. METHODS: This retrospective case study was carried out at a tertiary gynaecological cancer centre in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varughese, Elizabeth, Kondalsamy-Chennakesavan, Srinivas, Obermair, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337811/ https://www.ncbi.nlm.nih.gov/pubmed/22436532 http://dx.doi.org/10.1186/1757-2215-5-11

Ejemplares similares

Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study
por: Laky, Brenda, et al.
Publicado: (2010)

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
por: Fisken, J., et al.
Publicado: (1993)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.
por: Hawkins, R. E., et al.
Publicado: (1989)

Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis
por: Wang, Qingyi, et al.
Publicado: (2022)

The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
por: WEI, SU, et al.
Publicado: (2016)

Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study
por: Guo, Na, et al.
Publicado: (2017)

Prognostic value of serum CA-125 in patients with advanced epithelial ovarian cancer followed by complete remission after adjuvant chemotherapy
por: Moon, Jong Ho, et al.
Publicado: (2013)

Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer
por: Koh, Stephen Chee Liang, et al.
Publicado: (2012)

Serum CA125, CA199 and CEA Combined Detection for Epithelial Ovarian Cancer Diagnosis: A Meta-analysis
por: Guo, Junhong, et al.
Publicado: (2017)

The value of extended short-term medical training placements in smaller rural and remote locations on future work location: a cohort study
por: McGrail, Matthew R, et al.
Publicado: (2023)

Influence of legislations and news on Indian internet search query patterns of e-cigarettes
por: Thavarajah, Rooban, et al.
Publicado: (2017)

Prognostic Significance of Log(CA125)/PCI for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study
por: He, Can, et al.
Publicado: (2020)

Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125
por: Jin, Chunjing, et al.
Publicado: (2019)

The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer
por: Yang, Zhi-jun, et al.
Publicado: (2016)

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
por: Rong, Yan, et al.
Publicado: (2021)

The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent
por: Rajasooriyar, Chrishanthi, et al.
Publicado: (2014)

Impact of the COVID-19 Pandemic on Clinical Supervision of Healthcare Students in Rural Settings: A Qualitative Study
por: Martin, Priya, et al.
Publicado: (2022)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
por: Winarno, G. N. A., et al.
Publicado: (2020)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Preoperative Serum CA-125 Level As a Predictor for The Extent of Cytoreduction in Patients with Advanced Stage Epithelial Ovarian Cancer
por: Merlo, Sebastjan, et al.
Publicado: (2021)

Carcinoma of the cervix in elderly patients treated with radiotherapy: patterns of care and treatment outcomes
por: Lin, Ming Yin, et al.
Publicado: (2016)

Impact of the COVID‐19 pandemic on medical student placements in rural Queensland: A survey study
por: Martin, Priya, et al.
Publicado: (2022)

Value of serum miR-21, HE4 and CA125 in surveillance for postoperative recurrent or metastatic ovarian cancer
por: Gong, Zhenying, et al.
Publicado: (2022)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
por: Sánchez Vega, Juan Fernando, et al.
Publicado: (2018)

The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis
por: Micu, Romeo, et al.
Publicado: (2023)

CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer
por: Peters-Engl, C, et al.
Publicado: (1999)

The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.
por: Fisken, J., et al.
Publicado: (1993)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Retraction Note: The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer
por: Yang, Zhi-jun, et al.
Publicado: (2022)

Exploring Doctors’ Emerging Commitment to Rural and General Practice Roles over Their Early Career
por: McGrail, Matthew, et al.
Publicado: (2021)

Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol
por: Mutatiri, Clyson, et al.
Publicado: (2022)

The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer
por: Anastasi, Emanuela, et al.
Publicado: (2013)

Diagnostic value of the combination of circulating serum miRNAs and CA125 in endometriosis
por: Chen, Guansheng, et al.
Publicado: (2023)

Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2021)

CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels
por: Wang, Yi-Sheng, et al.
Publicado: (2021)

THE ROLE OF SALIVARY AND SERUM CA125 AND ROUTINE BLOOD TESTS IN PATIENTS WITH OVARIAN MALIGNANCIES
por: Vuković, Ante, et al.
Publicado: (2021)

Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer
por: Krell, Daniel, et al.
Publicado: (2017)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pvfq51u67lmkkvdebr1blpe0mq